Back to Treatments

Treatment

Mycophenolate Mofetil (MMF)

2
Conditions
115
Trials
15K
Participants
37%
Average Safety

Condition Evidence

Chronic kidney disease due to glomerulonephritis

100 trials · 15K participants

78% effectiveness · 35% safety

Pyoderma

15 trials · 400 participants

70% effectiveness · 38% safety
Mycophenolate Mofetil (MMF) | DFDA